These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 36550019)
21. Hsa_circ_0006692 Promotes Lung Cancer Progression via miR-205-5p/CDK19 Axis. Liao J; Chen Z; Luo X; Su Y; Huang T; Xu H; Lin K; Zheng Q; Zhang L; Lin G; Lin X Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627232 [TBL] [Abstract][Full Text] [Related]
22. Circ_ZFR contributes to the paclitaxel resistance and progression of non-small cell lung cancer by upregulating KPNA4 through sponging miR-195-5p. Li J; Fan R; Xiao H Cancer Cell Int; 2021 Jan; 21(1):15. PubMed ID: 33407505 [TBL] [Abstract][Full Text] [Related]
23. Circular RNAcirc_0076305 Promotes Cisplatin (DDP) Resistance of Non-Small Cell Lung Cancer Cells by Regulating Wang X; Wang H; Jiang H; Qiao L; Guo C Cancer Biother Radiopharm; 2023 Jun; 38(5):293-304. PubMed ID: 34339285 [No Abstract] [Full Text] [Related]
24. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis. Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072 [TBL] [Abstract][Full Text] [Related]
25. Oncogenic circ-SLC16A1 promotes progression of non-small cell lung cancer via regulation of the miR-1287-5p/profilin 2 axis. Jin M; Yuan T; Tian K; Li J; Huang Q; Chi Y; Huang G Cell Mol Biol Lett; 2024 Mar; 29(1):43. PubMed ID: 38539084 [TBL] [Abstract][Full Text] [Related]
26. Circ_0020123 promotes non-small cell lung cancer progression via miR-146a-5p mediated regulation of EIF4G2 expression. Wei Z; Liu J; Hui G; Luan X Thorac Cancer; 2024 Jan; 15(1):44-56. PubMed ID: 37993106 [TBL] [Abstract][Full Text] [Related]
27. Exosome-transferred hsa_circ_0014235 promotes DDP chemoresistance and deteriorates the development of non-small cell lung cancer by mediating the miR-520a-5p/CDK4 pathway. Xu X; Tao R; Sun L; Ji X Cancer Cell Int; 2020 Nov; 20(1):552. PubMed ID: 33292236 [TBL] [Abstract][Full Text] [Related]
28. Hsa_circ_0041268 promotes NSCLC progress by sponging miR-214-5p/ROCK1. Yang W; Wu L; Jin M J Clin Lab Anal; 2022 Apr; 36(4):e24262. PubMed ID: 35212425 [TBL] [Abstract][Full Text] [Related]
29. Hsa_circ_0069244 acts as the sponge of miR-346 to inhibit non-small cell lung cancer progression by regulating XPC expression. Shi J; Wang H; Feng W; Huang S; An J; Wang L; Jiang J Hum Cell; 2021 Sep; 34(5):1490-1503. PubMed ID: 34228324 [TBL] [Abstract][Full Text] [Related]
30. CircRNA has_circ_0017109 promotes lung tumor progression via activation of Wnt/β-catenin signaling due to modulating miR-671-5p/FZD4 axis. Yang B; Zhang B; Qi Q; Wang C BMC Pulm Med; 2022 Nov; 22(1):443. PubMed ID: 36434577 [TBL] [Abstract][Full Text] [Related]
31. Circ_SETD3 regulates gefitinib sensitivity and tumor progression by miR-873-5p-dependent regulation of APPBP2 in non-small cell lung cancer. Sheng J; Liu L; Dong T; Wu X J Chemother; 2022 Oct; 34(6):401-413. PubMed ID: 34861803 [TBL] [Abstract][Full Text] [Related]
32. CircRNA hsa_circ_0075048 promotes the malignant progression of non-small cell lung cancer by up-regulating HMGB2 expression via targeting miR-1225-5p. Zhang J; Mao J Histol Histopathol; 2023 Jun; 38(6):709-724. PubMed ID: 36416408 [TBL] [Abstract][Full Text] [Related]
33. Hsa_circ_0088036 promotes nonsmall cell lung cancer progression by regulating miR-1343-3p/Bcl-3 axis through TGFβ/Smad3/EMT signaling. Ge P; Chen X; Liu J; Jing R; Zhang X; Li H Mol Carcinog; 2023 Jul; 62(7):1073-1085. PubMed ID: 37132942 [TBL] [Abstract][Full Text] [Related]
34. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p. Dong Y; Xu T; Zhong S; Wang B; Zhang H; Wang X; Wang P; Li G; Yang S Life Sci; 2019 Dec; 239():116984. PubMed ID: 31647948 [TBL] [Abstract][Full Text] [Related]
35. Circ_0014235 confers Gefitinib resistance and malignant behaviors in non-small cell lung cancer resistant to Gefitinib by governing the miR-146b-5p/YAP/PD-L1 pathway. Niu R; Li D; Chen J; Zhao W Cell Cycle; 2022 Jan; 21(1):86-100. PubMed ID: 34919024 [TBL] [Abstract][Full Text] [Related]
36. Involvement of miR-4262 in paclitaxel resistance through the regulation of PTEN in non-small cell lung cancer. Sun H; Zhou X; Bao Y; Xiong G; Cui Y; Zhou H Open Biol; 2019 Jul; 9(7):180227. PubMed ID: 31337279 [TBL] [Abstract][Full Text] [Related]
37. CircRNA OXCT1 promotes the malignant progression and glutamine metabolism of non-small cell lung cancer by absorbing miR-516b-5p and upregulating SLC1A5. Luo H; Peng J; Yuan Y Cell Cycle; 2023 May; 22(10):1182-1195. PubMed ID: 35482822 [TBL] [Abstract][Full Text] [Related]
38. Circ-PITX1 promotes non-small-cell lung cancer progression through regulating ETS1 expression via miR-615-5p. Guo Y; Pan J; Gao X; Zheng Y Thorac Cancer; 2024 Sep; 15(27):1946-1957. PubMed ID: 39138880 [TBL] [Abstract][Full Text] [Related]
39. Circ_0069094 regulates malignant phenotype and paclitaxel resistance in breast cancer cells via targeting the miR-136-5p/YWHAZ axis. Kong Z; Han Q; Zhu B; Wan L; Feng E Thorac Cancer; 2023 Jul; 14(19):1831-1842. PubMed ID: 37192740 [TBL] [Abstract][Full Text] [Related]
40. Fuzheng Kang-Ai inhibits NSCLC cell proliferation via regulating hsa_circ_0048091/hsa-miR-378g/ARRDC3 pathway. Tang Q; Wang X; Zhou Q; Li Q; Yang X; Xu M; Wang R; Chen J; Wu W; Wang S Phytomedicine; 2023 Jun; 114():154819. PubMed ID: 37062135 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]